We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Poppy and Zach are a lifestyle store for babies and children. They currently have a destination store as well as a e-commerce store. The idea for the company was formed when the co-founder Bob Brinklow was searching for cool, fashionable clothing for his kids and noticed there was a gap in the market.  
days to go: Expired investment: £3,310
Active Food Systems, trading as Synergy Grill, has developed and patented innovative and commercial cooking technology for the food and hospitality industry. Its ‘Fat Atomising Grill' makes cleaning quick and easy while delivering cost savings through a 59% reduction in fuel consumption. The company has sold 2000+ units of the grill to entities like Whitbread, Greene King, Marriott, Radisson and Marstons among others. Synergy Grill asserts that its performance in the first half of the year has been profitable despite COVID-19. They have contracts with reputed organisations like Whitbread and Marstons have generated revenues of £970,000. The company is in conversation with over 50 pubs and restaurants including product trials with Nandos, Weatherspoons and Mitchell Butler that are interested in its product. It will use the investment to grow its business across different verticals.
days to go: Expired investment: £316,488
Making wine more accessible by using smart technology to deliver it to customer homes. sipp's range consists of more than 140 wines and the company has over 3,000 customers that have placed more than 7,000 orders. This has resulted in over 47,000 bottles sold since launching in July 2017. The sipp app offers customers’ insights into the origin of the wine by scanning the bottle label; customers can also re-purchase the same wine via this method. Profit is generated via wine sales and subscription services. The sippCLUB service allows customers to receive 3 bottles of wine every month for £29, including delivery. The company also offers single bottles of wine that can be purchased through the website, or app without a subscription. Funds are being raised to scale the business further by investing in marketing campaigns to increase brand awareness and acquire more customers. By 2021, sipp aims to serve over 100,000 users on its platform. In addition, contributions will be used to develop their proprietary technology further.
days to go: Expired investment: £357,797
Appetise is an online market place that connects consumers with local takeaway restaurants.  Consumers order food on their smart phones to be delivered by the restaurants to their homes.   They currently have 60,000 registered customers and 370 restaurants partnered in the UK and are looking to expand town by town and become a key player in this market.
days to go: Expired investment: £129,800
HealthBox Software is a technology company building products for the post-COVID healthcare landscape. Its first product, ClearPass, was met with success. The tool asks an employee a series of screening questions related to COVID-19, including evidence of fever, fatigue, and dry cough, etc. ClearPass has over 400,000 end-users including companies like Johnson Controls, Remy Cointreau and the San Diego School District. HealthBox aims to be a significant contender in the global digital health market that is expected to be worth $600 billion by 2026. The company is on the verge of launching another innovative product, MyHealthBox. It is a consumer-facing digital health app that will allow users to store their medical records, easily accessible 24/7. HealthBox asserts that the app will have an array of features, including AI health assessment services, dietary advice and data-powered lifestyle guidance. The company will use 47% of the investment towards technology and development costs, and 53% towards sales and marketing.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £144,265
Morso London is a modern community-centred restaurant that serves hand-crafted freshly made pasta and Italian bites with grappa-based cocktails. Launched in June 2018, the restaurant is created by a team of industry veterans. Paolo Vernetti is the Co-founder, head chef and CEO of Morso. Since Dec 2018, Morso has been TripAdvisor's Top 50 restaurant. The restaurant has received more than 100 5 star reviews. Morso was covered by Fay Maschler’s “Week in Food”, The Upcoming, The Infatuation and many other important food/media publications. Morso has achieved a 3x weekly sales growth from June 2018 to Jan 2019. It is achieving a positive site EBITDA on the 6th month of trading. Morso is planning to grow by opening two more sites in 2019.
days to go: Expired investment: £99,950
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph